Leading science, pioneering therapies

CRM Publications

Found 8 results
Filters: Keyword is Leukemia Inhibitory Factor Receptor alpha Subunit  [Clear All Filters]
Belmonte N, Phillips BW, Massiera F, Villageois P, Wdziekonski B, Saint-Marc P, Nichols J, Aubert J, Saeki K, Yuo A et al..  2001.  Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and -delta in preadipocytes.Mol Endocrinol. 15(11):2037-49.
Nichols J, Chambers I, Taga T, Smith A.  2001.  Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines.Development. 128(12):2333-9.
Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, Villageois P, Barhanin B, Vernallis A, Smith AG et al..  1999.  Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade.J Biol Chem. 274(35):24965-72.
Dani C, Chambers I, Johnstone S, Robertson M, Ebrahimi B, Saito M, Taga T, Li M, Burdon T, Nichols J et al..  1998.  Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.Dev Biol. 203(1):149-62.
Nichols J, Davidson D, Taga T, Yoshida K, Chambers I, Smith A.  1996.  Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis.Mech Dev. 57(2):123-31.
Li M, Sendtner M, Smith A.  1995.  Essential function of LIF receptor in motor neurons.Nature. 378(6558):724-7.
Yoshida K, Chambers I, Nichols J, Smith A, Saito M, Yasukawa K, Shoyab M, Taga T, Kishimoto T.  1994.  Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways.Mech Dev. 45(2):163-71.